Physician profile
Mark Alan Dobbertien
NPI 1265407043
$1,496.55
in general payments reported to CMS, 2019-2025
13 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2021: $96.37 · 2022: $398 · 2023: $228 · 2024: $168 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $669.51 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Davol INC. | $260.92 | 2023-2025 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $127.82 | 2019 | |
| Exact Sciences Corporation | $87.34 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $73.43 | 2023 | Watchman Access System |
| Medtronic, INC. | $55.71 | 2025 | Interstim |
| Biocompatibles, INC. | $50.00 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $43.74 | 2022 | |
| Inspire Medical Systems, INC. | $40.60 | 2025 | Inspire |
| Bridgebio Pharma, INC. | $30.49 | 2025 | Attruby |
| Medtronic Vascular, INC. | $26.87 | 2019 | |
| Philips North America LLC | $16.19 | 2023 | |
| Novartis Pharmaceuticals Corporation | $13.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dobbertien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.